Regulation of dopamine transporter function by protein-protein interactions: New discoveries and methodological challenges

Journal of Neurochemistry

Volumn 113, Issue 1, 2010, Pages 27-41

  Eriksen, Jacob ^a   Jørgensen, Trine Nygaard ^a   Gether, Ulrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biogenic amines; Dopaminergic neurons; Monoamines; Neurotransmitter transporters; Reuptake; Trafficking

Indexed keywords

ALPHA SYNUCLEIN; AMPHETAMINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CASPASE 2; CHEMOKINE RECEPTOR; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; EPSIN; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR 2; GLUTATHIONE TRANSFERASE; HEMAGGLUTININ; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NORADRENALIN TRANSPORTER; PARKIN; PROTEIN; PROTEIN HIC5; PROTEIN INTERACTING WITH PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN ZO1; PSYCHOSTIMULANT AGENT; SMALL INTERFERING RNA; SYNAPTOGYRIN 3; SYNTAXIN 1A; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO TERMINAL SEQUENCE; CATALYSIS; CELL MEMBRANE; CONDUCTANCE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; ENDOCYTOSIS; FLUORESCENCE; GENE MUTATION; HUMAN; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; PARKINSON DISEASE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SYNAPSE; UBIQUITINATION;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTRIC CONDUCTIVITY; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; ION TRANSPORT; MODELS, BIOLOGICAL; NEURONS; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECEPTORS, G-PROTEIN-COUPLED; UBIQUITINATION;

EID: 77749295404     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06599.x     Document Type: Review

References (134)

1. Adkins E. M., Samuvel D. J., Fog J. U., Eriksen J., Jayanthi L. D., Vaegter C. B., Ramamoorthy S. Gether U. (2007) Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching. Biochemistry 46, 10484 10497.
2. Albin R. L. Mink J. W. (2006) Recent advances in Tourette syndrome research. Trends Neurosci. 29, 175 182.
3. Baron A., Deval E., Salinas M., Lingueglia E., Voilley N. Lazdunski M. (2002) Protein kinase C stimulates the acid-sensing ion channel ASIC2a via the PDZ domain-containing protein PICK1. J. Biol. Chem. 277, 50463 50468. (Pubitemid 36042200)
4. Bauman A. L., Apparsundaram S., Ramamoorthy S., Wadzinski B. E., Vaughan R. A. Blakely R. D. (2000) Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci. 20, 7571 7578.
5. Beuming T., Shi L., Javitch J. A. Weinstein H. (2006) A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol. Pharmacol. 70, 1630 1642.
6. Beuming T., Kniazeff J., Bergmann M. L. et al. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat. Neurosci. 11, 780 789.
7. Binda F., Dipace C., Bowton E. et al. (2008) Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol. Pharmacol. 74, 1101 1108.
8. Bjerggaard C., Fog J. U., Hastrup H., Madsen K., Loland C. J., Javitch J. A. Gether U. (2004) Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions. J. Neurosci. 24, 7024 7036.
9. Bjorklund A. Dunnett S. B. (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci. 30, 194 202.
10. Bolan E. A., Kivell B., Jaligam V. et al. (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol. Pharmacol. 71, 1222 1232.
11. Boudanova E., Navaroli D. M., Stevens Z. Melikian H. E. (2008) Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization. Mol. Cell. Neurosci. 39, 211 217.
12. Browman K. E., Kantor L., Richardson S., Badiani A., Robinson T. E. Gnegy M. E. (1998) Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavioral studies. Brain Res. 814, 112 119.
13. Carlsson A., Lindqvist M. Magnusson T. (1957) 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180, 1200.
14. Carlsson A., Lindqvist M., Magnusson T. Waldeck B. (1958) On the presence of 3-hydroxytyramine in brain. Science 127, 471.
15. Carneiro A. M. Blakely R. D. (2006) Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. J. Biol. Chem. 281, 24769 24780.
16. Carneiro A. M., Ingram S. L., Beaulieu J. M., Sweeney A., Amara S. G., Thomas S. M., Caron M. G. Torres G. E. (2002) The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J. Neurosci. 22, 7045 7054.
17. Carvelli L., Moron J. A., Kahlig K. M. et al. (2002) PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81, 859 869.
18. Carvelli L., McDonald P. W., Blakely R. D. DeFelice L. J. (2004) Dopamine transporters depolarize neurons by a channel mechanism. Proc. Natl Acad. Sci. USA 101, 16046 16051.
19. Carvelli L., Blakely R. D. DeFelice L. J. (2008) Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc. Natl Acad. Sci. USA 105, 14192 14197.
20. Cervinski M. A., Foster J. D. Vaughan R. A. (2005) Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms. J. Biol. Chem. 280, 40442 40449.
21. Cha J. H., Zou M. F., Adkins E. M., Rasmussen S. G., Loland C. J., Schoenenberger B., Gether U. Newman A. H. (2005) Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter. J. Med. Chem. 48, 7513 7516.
22. Chandra S., Fornai F., Kwon H. B. et al. (2004) Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc. Natl Acad. Sci. USA 101, 14966 14971.
23. Chen N. H., Reith M. Quick M. (2004) Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch. Eur. J. Physiol. 447, 519 531.
24. Chen R., Tilley M. R., Wei H. et al. (2006) Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. PNAS 103, 9333 9338.
25. Chen R., Furman C. A., Zhang M., Kim M. N., Gereau R. W., IV., Leitges M. Gnegy M. E. (2009) Protein kinase C{beta} is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. J. Pharmacol. Exp. Ther. 328, 912 920.
26. Chi L. Reith M. E. A. (2003) Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J. Pharmacol. Exp. Ther. 307, 729 736.
27. Ciccone M. A., Timmons M., Phillips A. Quick M. W. (2008) Calcium/calmodulin-dependent kinase II regulates the interaction between the serotonin transporter and syntaxin 1A. Neuropharmacology 55, 763 770.
28. Copeland B. J., Vogelsberg V., Neff N. H. Hadjiconstantinou M. (1996) Protein kinase C activators decrease dopamine uptake into striatal synaptosomes. J. Pharmacol. Exp. Ther. 277, 1527 1532.
29. Cowell R. M., Kantor L., Hewlett G. H. K., Frey K. A. Gnegy M. E. (2000) Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur. J. Pharmacol. 389, 59 65.
30. Daniels G. M. Amara S. G. (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 35794 35801.
31. Dauer W., Kholodilov N., Vila M. et al. (2002) Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl Acad. Sci. USA 99, 14524 14529.
32. Daws L. C., Callaghan P. D., Moron J. A., Kahlig K. M., Shippenberg T. S., Javitch J. A. Galli A. (2002) Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem. Biophys. Res. Commun. 290, 1545 1550.
33. Deken S. L., Beckman M. L., Boos L. Quick M. W. (2000) Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A. Nat. Neurosci. 3, 998 1003.
34. Dipace C., Sung U., Binda F., Blakely R. D. Galli A. (2007) Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Mol. Pharmacol. 71, 230 239.
35. Egana L. A., Cuevas R. A., Baust T. B. et al. (2009) Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J. Neurosci. 29, 4592 4604.
36. Eriksen J., Rasmussen S. G. F., Rasmussen T. N., Vaegter C. B., Cha J. H., Zou M. F., Newman A. H. Gether U. (2009) Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs. J. Neurosci. 29, 6794 6808.
37. Farhan H., Korkhov V. M., Paulitschke V., Dorostkar M. M., Scholze P., Kudlacek O., Freissmuth M. Sitte H. H. (2004) Two discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat gamma-aminobutyric acid transporter-1 (GAT1). J. Biol. Chem. 279, 28553 28563.
38. Farhan H., Freissmuth M. Sitte H. H. (2006) Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane. Handb. Exp. Pharmacol. 175, 233 249.
39. Farhan H., Reiterer V., Korkhov V. M., Schmid J. A., Freissmuth M. Sitte H. H. (2007) Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D. J. Biol. Chem. 282, 7679 7689.
40. Fog J. U., Khoshbouei H., Holy M. et al. (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417 429.
41. Foster J. D., Pananusorn B. Vaughan R. A. (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 277, 25178 25186.
42. Foster J. D., Adkins S. D., Lever J. R. Vaughan R. A. (2008) Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J. Neurochem. 105, 1683 1699.
43. Fountaine T. M. Wade-Martins R. (2007) RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport. J. Neurosci. Res. 85, 351 363.
44. Fountaine T. M., Venda L. L., Warrick N., Christian H. C., Brundin P., Channon K. M. Wade-Martins R. (2008) The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons. Eur. J. Neurosci. 28, 2459 2473.
45. Fumagalli F., Gainetdinov R. R., Valenzano K. J. Caron M. G. (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18, 4861 4869.
46. Garcia B. G., Wei Y., Moron J. A., Lin R. Z., Javitch J. A. Galli A. (2005) Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol. Pharmacol. 68, 102 109.
47. Gether U. (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21, 90 113.
48. Gether U., Andersen P. H., Larsson O. M. Schousboe A. (2006) Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol. Sci. 27, 375 383.
49. Giros B., Jaber M., Jones S. R., Wightman R. M. Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606 612.
50. Gorentla B. K., Moritz A. E., Foster J. D. Vaughan R. A. (2009) Proline-directed phosphorylation of the dopamine transporter N-terminal domain. Biochemistry 48, 1067 1076.
51. Granas C., Ferrer J., Loland C. J., Javitch J. A. Gether U. (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J. Biol. Chem. 278, 4990 5000.
52. Greene J. G. (2006) Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease. J. Physiol. 575, 411 416.
53. Groc L. Choquet D. (2008) Measurement and characteristics of neurotransmitter receptor surface trafficking (Review). Mol. Membr. Biol. 25, 344 352.
54. Gu H., Wall S. C. Rudnick G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 7124 7130.
55. Gubernator N. G., Zhang H., Staal R. G. W. et al. (2009) Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals. Science 324, 1441 1444.
56. Hanley J. G. Henley J. M. (2005) PICK1 is a calcium-sensor for NMDA-induced AMPA receptor trafficking. EMBO J. 24, 3266 3278.
57. Hastrup H., Karlin A. Javitch J. A. (2001) Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc. Natl Acad. Sci. USA 98, 10055 10060.
58. Hersch S. M., Yi H., Heilman C. J., Edwards R. H. Levey A. I. (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J. Comp. Neurol. 388, 211 227.
59. Holton K. L., Loder M. K. Melikian H. E. (2005) Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat. Neurosci. 8, 881 888.
60. Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y. Takahashi R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891 902.
61. Ingram S. L., Prasad B. M. Amara S. G. (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat. Neurosci. 5, 971 978.
62. Iversen S. D. Iversen L. L. (2007) Dopamine: 50 years in perspective. Trends Neurosci. 30, 188 193.
63. Jayanthi L. D., Samuvel D. J., Blakely R. D. Ramamoorthy S. (2005) Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Mol. Pharmacol. 67, 2077 2087.
64. Jeannotte A. M. Sidhu A. (2007) Regulation of the norepinephrine transporter by alpha-synuclein-mediated interactions with microtubules. Eur. J. Neurosci. 26, 1509 1520.
65. Johnson L. A., Guptaroy B., Lund D., Shamban S. Gnegy M. E. (2005) Regulation of amphetamine-stimulated dopamine efflux by protein kinase C {beta}. J. Biol. Chem. 280, 10914 10919.
66. Jones S. R., Gainetdinov R. R., Jaber M., Giros B., Wightman R. M. Caron M. G. (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl Acad. Sci. USA 95, 4029 4034.
67. Jorgensen S., Nielsen E. Ï., Peters D. Dyhring T. (2008) Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity. J. Neurosci. Methods 169, 168 176.
68. Kahlig K. M., Binda F., Khoshbouei H., Blakely R. D., McMahon D. G., Javitch J. A. Galli A. (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc. Natl Acad. Sci. USA 102, 3495 3500.
69. Kantor L. Gnegy M. E. (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J. Pharmacol. Exp. Ther. 284, 592 598.
70. Khoshbouei H., Sen N., Guptaroy B., Johnson L., Lund D., Gnegy M. E., Galli A. Javitch J. A. (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2, E78.
71. Kim E. Sheng M. (2004) PDZ domain proteins of synapses. Nat. Rev. Neurosci. 5, 771 781.
72. Kniazeff J., Shi L., Loland C. J., Javitch J. A., Weinstein H. Gether U. (2008) An intracellular interaction network regulates conformational transitions in the dopamine transporter. J. Biol. Chem. 283, 17691 17701.
73. Krueger B. K. (1990) Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J. Neurochem. 55, 260 267.
74. Kruger R., Kuhn W., Muller T. et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106 108.
75. Lammel S., Hetzel A., Hckel O., Jones I., Liss B. Roeper J. (2008) Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57, 760 773.
76. Lee F. J., Liu F., Pristupa Z. B. Niznik H. B. (2001) Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J. 15, 916 926.
77. Lee K. H., Kim M. Y., Kim D. H. Lee Y. S. (2004) Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter. Neurochem. Res. 29, 1405 1409.
78. Lee F. J., Pei L., Moszczynska A., Vukusic B., Fletcher P. J. Liu F. (2007) Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J. 26, 2127 2136.
79. Lee F. J., Pei L. Liu F. (2009) Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia. Synapse 63, 710 712.
80. LeWitt P. A. (2008) Levodopa for the treatment of Parkinson's disease. N. Engl. J. Med. 359, 2468 2476.
81. Lin D. T. Huganir R. L. (2007) PICK1 and phosphorylation of the glutamate receptor 2 (GluR2) AMPA receptor subunit regulates GluR2 recycling after NMDA receptor-induced internalization. J. Neurosci. 27, 13903 13908.
82. Maiya R., Ponomarev I., Linse K. D., Harris R. A. Mayfield R. D. (2007) Defining the dopamine transporter proteome by convergent biochemical and in silico analyses. Genes Brain Behav. 6, 97 106.
83. Marazziti D., Golini E., Mandillo S., Magrelli A., Witke W., Matteoni R. Tocchini-Valentini G. P. (2004) Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptor. PNAS 101, 10189 10194.
84. Marazziti D., Mandillo S., Di Pietro C., Golini E., Matteoni R. Tocchini-Valentini G. P. (2007) GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs. PNAS 104, 9846 9851.
85. Mazei-Robison M. S. Blakely R. D. (2005) Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala. Neuropharmacology 49, 737 749.
86. McDonald P. W., Hardie S. L., Jessen T. N., Carvelli L., Matthies D. S. Blakely R. D. (2007) Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1. J. Neurosci. 27, 14216 14227.
87. Mehrens T., Lelleck S., Cetinkaya I., Knollmann M., Hohage H., Gorboulev V., Boknik P., Koepsell H. Schlatter E. (2000) The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. J. Am. Soc. Nephrol. 11, 1216 1224.
88. Meinild A. K., Sitte H. H. Gether U. (2004) Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter. J. Biol. Chem. 279, 49671 49679.
89. Melikian H. E. Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 7699 7710.
90. Miranda M., Wu C. C., Sorkina T., Korstjens D. R. Sorkin A. (2005) Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C. J. Biol. Chem. 280, 35617 35624.
91. Miranda M., Dionne K. R., Sorkina T. Sorkin A. (2007) Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol. Biol. Cell 18, 313 323.
92. Montagu K. A. (1957) Catechol compounds in rat tissues and in brains of different animals. Nature 180, 244 245.
93. Moron J. A., Zakharova I., Ferrer J. V. et al. (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J. Neurosci. 23, 8480 8488.
94. Moszczynska A., Saleh J., Zhang H., Vukusic B., Lee F. J. Liu F. (2007) Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity. J. Mol. Neurosci. 32, 217 227.
95. Nestler E. J. (2005) The neurobiology of cocaine addiction. Sci. Pract. Perspect. 3, 4 10.
96. Nourry C., Grant S. G. N. Borg J. P. (2003) PDZ domain proteins: plug and play Sci. STKE 2003, re7.
97. Ohyama A., Hosaka K., Komiya Y. et al. (2002) Regulation of exocytosis through Ca2+/ATP-dependent binding of autophosphorylated Ca2+/calmodulin- activated protein kinase II to syntaxin 1A. J. Neurosci. 22, 3342 3351.
98. Perez J. L., Khatri L., Chang C., Srivastava S., Osten P. Ziff E. B. (2001) PICK1 targets activated protein kinase C{alpha} to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2. J. Neurosci. 21, 5417 5428.
99. Pifl C. Singer E. A. (1999) Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Mol. Pharmacol. 56, 1047 1054.
100. Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045 2047.
101. Quick M. W. (2003) Regulating the conducting states of a mammalian serotonin transporter. Neuron 40, 537 549.
102. Raiborg C. Stenmark H. (2009) The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458, 445 452.
103. Rayport S., Sulzer D., Shi W. X., Sawasdikosol S., Monaco J., Batson D. Rajendran G. (1992) Identified postnatal mesolimbic dopamine neurons in culture: morphology and electrophysiology. J. Neurosci. 12, 4264 4280.
104. Saunders C., Ferrer J. V., Shi L. et al. (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl Acad. Sci. USA 97, 6850 6855.
105. Schapira A. H. V. (2009) Neurobiology and treatment of Parkinson's disease. Trends Pharmacol. Sci. 30, 41 47.
106. Scholze P., Freissmuth M. Sitte H. H. (2002a) Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J. Biol. Chem. 277, 43682 43690.
107. Scholze P., Norregaard L., Singer E. A., Freissmuth M., Gether U. Sitte H. H. (2002b) The role of zinc ions in reverse transport mediated by monoamine transporters. J. Biol. Chem. 277, 21505 21513.
108. Schwartz J. W., Blakely R. D. DeFelice L. J. (2003) Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate. J. Biol. Chem. 278, 9768 9777.
109. Schwartz J. W., Novarino G., Piston D. W. DeFelice L. J. (2005) Substrate binding stoichiometry and kinetics of the norepinephrine transporter. J. Biol. Chem. 280, 19177 19184.
110. Silva N. L., Mariani A. P., Harrison N. L. Barker J. L. (1988) 5,7-Dihydroxytryptamine identifies living dopaminergic neurons in mesencephalic cultures. Proc. Natl Acad. Sci. USA 85, 7346 7350.
111. Singleton A. B., Farrer M., Johnson J. et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302, 841.
112. Sitte H. H., Huck S., Reither H., Boehm S., Singer E. A. Pifl C. (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J. Neurochem. 71, 1289 1297.
113. Sitte H. H., Farhan H. Javitch J. A. (2004) Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol. Interv. 4, 38 47.
114. Sonders M. S., Zhu S. J., Zahniser N. R., Kavanaugh M. P. Amara S. G. (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17, 960 974.
115. Sorkina T., Doolen S., Galperin E., Zahniser N. R. Sorkin A. (2003) Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J. Biol. Chem. 278, 28274 28283.
116. Sorkina T., Hoover B. R., Zahniser N. R. Sorkin A. (2005) Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6, 157 170.
117. Sorkina T., Miranda M., Dionne K. R., Hoover B. R., Zahniser N. R. Sorkin A. (2006) RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis. J. Neurosci. 26, 8195 8205.
118. Sorkina T., Richards T. L., Rao A., Zahniser N. R. Sorkin A. (2009) Negative regulation of dopamine transporter endocytosis by membrane-proximal N-terminal residues. J. Neurosci. 29, 1361 1374.
119. Sulzer D., Sonders M. S., Poulsen N. W. Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406 433.
120. Sung U., Apparsundaram S., Galli A., Kahlig K. M., Savchenko V., Schroeter S., Quick M. W. Blakely R. D. (2003) A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J. Neurosci. 23, 1697 1709.
121. Thomsen M., Han D. D., Gu H. H. Caine S. B. (2009) Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. J. Pharmacol. Exp. Ther. 331, 204 211.
122. Tomlinson I. D., Mason J. N., Blakely R. D. Rosenthal S. J. (2005) Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots. Bioorg. Med. Chem. Lett. 15, 5307 5310.
123. Tomlinson I. D., Mason J. N., Blakely R. D. Rosenthal S. J. (2006) High affinity inhibitors of the dopamine transporter (DAT): novel biotinylated ligands for conjugation to quantum dots. Bioorg. Med. Chem. Lett. 16, 4664 4667.
124. Torres G. E. Amara S. G. (2007) Glutamate and monoamine transporters: new visions of form and function. Curr. Opin. Neurobiol. 17, 304 312.
125. Torres G. E., Yao W. D., Mohn A. R., Quan H., Kim K. M., Levey A. I., Staudinger J. Caron M. G. (2001) Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30, 121 134.
126. Torres G. E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W. D. Caron M. G. (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278, 2731 2739.
127. Vaughan R. A., Huff R. A., Uhl G. R. Kuhar M. J. (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 15541 15546.
128. Wall S. C., Gu H. Rudnick G. (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol. Pharmacol. 47, 544 550.
129. Wersinger C. Sidhu A. (2003) Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with alpha-synuclein and its familial Parkinson's disease-linked mutants. Neurosci. Lett. 342, 124 128.
130. Williams J. M., Owens W. A., Turner G. H. et al. (2007) Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol. 5, e274.
131. Yamashita A., Singh S. K., Kawate T., Jin Y. Gouaux E. (2005) Crystal structure of a bacterial homologue of Na+/Cl - dependent neurotransmitter transporters. Nature 437, 215 223.
132. Zapata A., Kivell B., Han Y. et al. (2007) Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J. Biol. Chem. 282, 35842 35854.
133. Zarranz J. J., Alegre J., Gomez-Esteban J. C. et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164 173.
134. Zhu S. J., Kavanaugh M. P., Sonders M. S., Amara S. G. Zahniser N. R. (1997) Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 282, 1358 1365.